Mouwasat Medical Services Co. reported a net profit after Zakat and tax of SAR 150.2 million for Q1 2022, a 2% increase from SAR 147.2 million in the same period a year earlier.
| Item | Q1 2021 | Q1 2022 | Change |
|---|---|---|---|
| Revenues | 534.12 | 566.97 | 6.1 % |
| Gross Income | 254.30 | 267.78 | 5.3 % |
| Operating Income | 158.49 | 159.68 | 0.8 % |
| Net Income | 147.19 | 150.21 | 2.1 % |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 0.74 | 0.75 | 2.1 % |
| Item | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Revenues | 552.33 | 566.97 | 2.6 % |
| Gross Income | 250.62 | 267.78 | 6.8 % |
| Operating Income | 158.56 | 159.68 | 0.7 % |
| Net Income | 146.97 | 150.21 | 2.2 % |
| Average Shares | 200.00 | 200.00 | - |
| EPS (Riyals) | 0.73 | 0.75 | 2.2 % |
The profit rise is attributed to higher revenue resulting from continuous effective utilization of newly-specialized resources and enhancement of their operating efficiency. The company also cited higher other revenue and lower financing costs for the increase in net profit.
Sequentially, Mouwasat’s net profit rose 2.2% in Q1 2022 from SAR 147 million in Q4 2021.
Total shareholders’ equity stood at SAR 2.754 billion as of March 31, 2022, increasing by 13.5% from SAR 2.426 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}